Income StatementBalance SheetCash FlowSegments
Ameriprise Financial logo

Ameriprise Financial Cash Flow Statement

Operating, investing, and financing cash movements

Ameriprise Financial generated $7.1B in operating cash flow over the trailing twelve months. After $155.0M in capital expenditures, free cash flow was $6.9B. Free cash flow increased 0.0% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$7.1BNet Cash From Investing (TTM)-$456.0MNet Cash From Financing (TTM)-$6.2BCapital Expenditures (TTM)$155.0MDepreciation And Amortization Cf (TTM)-$75.0MNet Change In Cash (TTM)$434.0M
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$42.2B
P/E Ratio10.83
ROE66.94%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in fair value of equity securities$2.0M$1.0M$1.0M$2.0M$2.0M$1.0M
Change in accounts payable$132.0M-$452.0M$179.0M$246.0M$288.0M-$467.0M
Change in income taxes payable/receivable$26.0M$180.0M-$593.0M$137.0M—$240.0M
Other working capital changes—-$293.0M$136.0M-$184.0M—-$308.0M
Change in receivables$0.0$220.0M-$117.0M$348.0M—$269.0M
Deferred income taxes—-$95.0M$202.0M$80.0M—-$19.0M
Depreciation and amortization-$34.0M-$27.0M-$27.0M-$19.0M-$20.0M-$9.0M
Net cash from operating activities$383.0M$1.7B$1.8B$2.2B$2.7B$459.0M
Net income$1.1B$583.0M$1.1B$912.0M$1.0B$915.0M
Change in Other Operating Assets and Liabilities of Consolidated Investment Entities$0.0-$2.0M-$5.0M$2.0M-$1.0M$7.0M
Consolidated Investment Entities Unrealized Realized Gain (Loss) on Assets and Liabilities$18.0M-$12.0M$5.0M$3.0M-$8.0M-$9.0M
Derivatives, net of collateral-$528.0M$270.0M-$545.0M-$572.0M—-$1.0B
Gain (Loss) on Sale of Investments-$15.0M$5.0M-$15.0M$11.0M$2.0M$0.0
Equity in earnings (losses) of equity method investees-$6.0M-$13.0M$4.0M$6.0M-$5.0M-$6.0M
Brokerage deposits-$300.0M-$25.0M-$121.0M-$69.0M-$170.0M$14.0M
Increase (Decrease) in Deferred Policy Acquisition Costs-$9.0M-$16.0M-$14.0M-$13.0M-$9.0M-$13.0M
Impairments and provision for loan and credit losses$4.0M-$5.0M$1.0M$11.0M$12.0M-$1.0M
Stock-based compensation$55.0M$49.0M$46.0M$50.0M$61.0M$39.0M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in Restricted Investments-$104.0M-$158.0M-$319.0M$0.0$0.0$0.0
Capital expenditures$58.0M$36.0M$38.0M$44.0M$44.0M$29.0M
Payments for Derivative Instruments (Investing)$0.0$0.0$0.0$0.0$50.0M$73.0M
Payment to Acquire Investments by Consolidated Investment Entities$334.0M$354.0M$377.0M$333.0M$367.0M$259.0M
Payments for Other Deposits$8.0M$8.0M$7.0M$7.0M$7.0M$7.0M
Payment for (Proceeds from) Other Investing Activity$49.0M$10.0M$39.0M$34.0M$323.0M$26.0M
Payments to Acquire Mortgage Notes Receivable$104.0M$107.0M$133.0M$210.0M$263.0M$207.0M
Payments to Acquire Other Investments$5.0M$26.0M$15.0M$6.0M$4.0M$3.0M
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale$4.5B$4.2B$4.3B$4.6B$3.9B$2.9B
Proceeds from short-term investment in time deposit$122.0M$112.0M$117.0M$101.0M$97.0M$97.0M
Proceeds from Sale and Collection of Mortgage Notes Receivable$47.0M$37.0M$49.0M$67.0M$87.0M$111.0M
Sale of investments$530.0M$1.1B$498.0M$328.0M$253.0M$602.0M
Proceeds from sales, maturities and repayments of investments by consolidated investment entities$417.0M$167.0M$259.0M$237.0M$325.0M$245.0M
Proceeds from other investments$21.0M$22.0M$29.0M$10.0M$9.0M$13.0M
Net cash from investing activities-$783.0M-$1.7B$802.0M$1.0B-$1.6B-$669.0M
Purchases of investments$5.9B$6.8B$3.8B$3.7B$5.2B$4.1B
Investing Cash Flows from Derivatives$0.0$0.0$5.0M$0.0$15.0M$18.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Repayments of debt$553.0M$3.0M$503.0M$2.0M$2.0M$0.0
Dividends paid$144.0M$144.0M$152.0M$151.0M$149.0M$148.0M
Policyholder contract deposits$376.0M$254.0M$336.0M$377.0M$326.0M$266.0M
Borrowings of consolidated investment entities$390.0M$304.0M$387.0M$126.0M$303.0M$0.0
Increase (Decrease) in Deposits$576.0M$363.0M-$172.0M$95.0M$1.1B$109.0M
Proceeds from additions$1.1B$961.0M$791.0M$695.0M$617.0M$586.0M
Investment Certificates and Banking Time Deposits Maturities Withdrawals and Cash Surrenders$1.9B$1.5B$1.6B$1.7B$1.4B$1.2B
Net transfers from (to) separate accounts$300.0M-$36.0M-$35.0M-$47.0M$281.0M-$39.0M
Proceeds from new debt$0.0$740.0M$0.0$0.0$1.0M$0.0
Repayments of Debt of Consolidated Investment Entities$226.0M$328.0M$34.0M$256.0M$304.0M$1.0M
Withdrawal from Contract Holders Funds$380.0M$395.0M$356.0M$359.0M$377.0M$327.0M
Payments for Derivative Financing Activities$26.0M$3.0M$37.0M$31.0M$50.0M$55.0M
Proceeds from Derivative Financing Activities$48.0M$0.0$0.0$46.0M$50.0M$110.0M
Net cash from financing activities-$1.5B-$488.0M-$1.9B-$1.9B-$871.0M-$1.5B
Repurchases of common stock$665.0M$730.0M$581.0M$701.0M$895.0M$874.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$325.0M$1.7B$1.7B$2.2B$2.6B$430.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$32.0M$13.0M$25.0M-$8.0M$1.0M-$9.0M
Net increase (decrease) in cash—-$530.0M$651.0M$1.3B$206.0M-$1.8B

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
ROU Asset Obtained for Lease Liability$16.0M$22.0M$12.0M$8.0M$8.0M$11.0M
Health care costs payable and other insurance liabilities$386.0M$940.0M$1.2B$1.6B$829.0M$728.0M